Doctor Josephine Harrington
Duke Clinical Research Institute, Durham (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence
Event: ESC Congress 2022
Topic: Anticoagulants
Session: How to balance efficacy and safety of anticoagulant therapy in clinical practice
ESC 365 is supported by
